Catalent Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CATALENT, and what generic and branded alternatives to CATALENT drugs are available?
CATALENT has three approved drugs.
Summary for Catalent
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
| PTAB Cases with Catalent as petitioner: | See PTAB cases with Catalent as petitioner |
Drugs and US Patents for Catalent
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Catalent | NAPROXEN SODIUM | naproxen sodium | CAPSULE;ORAL | 202807-001 | Jan 4, 2019 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Catalent | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | CAPSULE;ORAL | 213105-001 | Sep 21, 2020 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Catalent | VALPROIC ACID | valproic acid | CAPSULE;ORAL | 073229-001 | Oct 29, 1991 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
